Company Encyclopedia
View More
name
JINHAI MED TECH
02225.HK
Jinhai Medical Technology Limited, an investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore. It also offers manpower outsourcing and ancillary services to building and construction contractors. In addition, the company provides IT services; construction ancillary services, such as warehousing, cleaning, and building maintenance services; and dormitory services. Further, it offers engineering design and consultancy services, as well as sells graphene material products.
88.51 B
02225.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Human Resource and Employment ServicesIndustry
Industry Ranking8/8
Industry medianB
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-68.29%E
    • Profit Margin-57.10%E
    • Gross Margin14.33%D
  • Growth ScoreE
    • Revenue YoY-33.41%E
    • Net Profit YoY-123.85%E
    • Total Assets YoY-17.42%E
    • Net Assets YoY-21.32%E
  • Cash ScoreE
    • Cash Flow Margin-175.12%D
    • OCF YoY-33.41%E
  • Operating ScoreB
    • Turnover0.68B
  • Debt ScoreC
    • Gearing Ratio44.62%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    JINHAI MED TECH's subsidiary has signed a strategic cooperation framework agreement to promote and track spinal endoscopy technology

    According to a report from Economic Information Daily on the 6th, JINHAI MED TECH announced that its subsidiary JINHAI Shanghai has signed a strategic cooperation framework agreement with Medtronic's subsidiary Medtronic Changzhou to strategically cooperate on the promotion of real-time navigation and tracking endoscopic spine technology for clinical applications in China. (rh)

    etnet·
    HK
    02225
    +3.42%
    US
    MDT
    +0.02%
    etnet·
    HK
    02225
    +3.42%
    US
    MDT
    +0.02%

    JINHAI MED TECH: JINHAI MED TECH is actively preparing to participate in the 8th China International Import Expo

    JINHAI MED TECH announced that its wholly-owned subsidiary is actively preparing to participate in the 8th China International Import Expo, which will be held in Shanghai from November 5 to 10, 2025. During the event, JINHAI MED TECH will jointly release the latest navigation-based spinal endoscopy innovative technology with Medtronic China, aiming to enhance the precision and intelligence of spinal surgery, shorten the learning curve for doctors, and promote clinical applications. Medtronic is a global leader in medical technology and has participated in the expo for seven consecutive years

    Zhitong·
    US
    MDT
    +0.02%
    HK
    02225
    +3.42%
    Zhitong·
    US
    MDT
    +0.02%
    HK
    02225
    +3.42%

    JINHAI MED TECH: Huang Wenyiao has been appointed as the company secretary

    According to the Zhitong Finance APP, JINHAI MED TECH announced that Ms. Zheng Yuan has resigned as (i) the company secretary, (ii) authorized representative, and (iii) legal process agent, effective from September 29, 2025. Mr. Huang Wenyiao has been appointed as the company secretary, authorized representative, and legal process agent, effective from September 29, 2025, to fill the vacancy left by Ms. Zheng's resignation

    Zhitong·
    HK
    02225
    +3.42%
    Zhitong·
    HK
    02225
    +3.42%

    Understanding the Market | JINHAI MED TECH rose over 41% in the afternoon, with a cumulative increase of over 80% after earnings; previously, the placement of shares was used to raise funds for potential mergers and acquisitions and investment projects

    In the afternoon, JINHAI MED TECH's stock price rose over 41%, with a cumulative increase of more than 80% after the earnings report. As of the time of writing, the stock price is HKD 0.92, with a trading volume of HKD 24.8559 million. The company's interim results show a year-on-year revenue decrease of 43.98%, and the loss attributable to shareholders has widened by 69.67%. The company plans to raise HKD 161 million through a rights issue for potential mergers and acquisitions, investment projects, research and development expenses, and general working capital

    Zhitong·
    HK
    02225
    +3.42%
    Zhitong·
    HK
    02225
    +3.42%

    JINHAI MED TECH released its interim results, with a loss attributable to shareholders of SGD 10.253 million, an increase of 69.67% year-on-year

    According to the Zhitong Finance APP, JINHAI MED TECH released its interim results for the six months ending June 30, 2025, reporting group revenue of SGD 14.529 million, a year-on-year decrease of 43.98%; loss attributable to shareholders of SGD 10.253 million, a year-on-year increase of 69.67%; and a loss per share of 0.2 Singapore cents

    Zhitong·
    HK
    02225
    +3.42%
    Zhitong·
    HK
    02225
    +3.42%
    © 2025 Longbridge｜Disclaimer